Mumbai, June 18, 2010: Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Xanax ®, alprazolam tablets.

These generic alprazolam tablets, equivalent to Pfizer’s Xanax ® tablets, include four strengths: 0.25 mg, 0.5 mg, 1 mg and 2 mg. Annual sale in US for these strengths of branded and generic alprazolam tablets is estimated at $ 145 million.

Alprazolam tablets are indicated for the management of anxiety disorder or the short-term relief of symptoms of anxiety. It is also indicated for the treatment of panic disorder, with our without agoraphobia.

Xanax ® is a registered trademark of Pfizer.